Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Hoellwerth

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancers|January 11, 2025
Therapeutic Approaches for Advanced Basal Cell Carcinoma: A Comprehensive ReviewMagdalena Hoellwerth, Matthias Brandlmaier, Peter Koelblinger
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 26, 2024
Blistering erythema on the right shoulderMatthias Brandlmaier, Magdalena Hoellwerth, Demetrios Papadopoulos, et al.
Life (Basel, Switzerland)|February 25, 2023
Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker ResearchMagdalena Hoellwerth, Peter Koelblinger, Roland Lang, et al.
JAAD Case Reports|October 13, 2025
Eyelid nodule with persistent growthMagdalena Hoellwerth, Matthias Brandlmaier, Sylvia Selhofer, et al.
Cancers|April 27, 2024
Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet RadiationMatthias Brandlmaier, Magdalena Hoellwerth, Peter Koelblinger, et al.
The British Journal of Dermatology|December 19, 2023
Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trialDamian Meyersburg, Magdalena Hoellwerth, Matthias Brandlmaier, et al.
Journal of Clinical Medicine|September 28, 2021
COVID-19-Induced Reduction in Primary Melanoma Diagnoses: Experience from a Dermatopathology Referral CenterMagdalena Hoellwerth, Andreas Kaiser, Michael Emberger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2023
Predictive value and accuracy of [<sup>18</sup>F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanomaNarjess Ayati, Zahra Jamshidi-Araghi, Magdalena Hoellwerth, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
Peter Koelblinger, Magdalena Hoellwerth, Marie-Therese Dernoscheg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 13, 2021
Adjuvant anti-PD-1 antibody treatment in stage III/IV melanoma: real-world experience and health economic considerationsPeter Koelblinger, Magdalena Hoellwerth, Marie-Therese Dernoscheg, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancers|January 11, 2025
Therapeutic Approaches for Advanced Basal Cell Carcinoma: A Comprehensive ReviewMagdalena Hoellwerth, Matthias Brandlmaier, Peter Koelblinger
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 26, 2024
Blistering erythema on the right shoulderMatthias Brandlmaier, Magdalena Hoellwerth, Demetrios Papadopoulos, et al.
Life (Basel, Switzerland)|February 25, 2023
Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker ResearchMagdalena Hoellwerth, Peter Koelblinger, Roland Lang, et al.
JAAD Case Reports|October 13, 2025
Eyelid nodule with persistent growthMagdalena Hoellwerth, Matthias Brandlmaier, Sylvia Selhofer, et al.
Cancers|April 27, 2024
Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet RadiationMatthias Brandlmaier, Magdalena Hoellwerth, Peter Koelblinger, et al.
The British Journal of Dermatology|December 19, 2023
Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trialDamian Meyersburg, Magdalena Hoellwerth, Matthias Brandlmaier, et al.
Journal of Clinical Medicine|September 28, 2021
COVID-19-Induced Reduction in Primary Melanoma Diagnoses: Experience from a Dermatopathology Referral CenterMagdalena Hoellwerth, Andreas Kaiser, Michael Emberger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2023
Predictive value and accuracy of [<sup>18</sup>F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanomaNarjess Ayati, Zahra Jamshidi-Araghi, Magdalena Hoellwerth, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
Peter Koelblinger, Magdalena Hoellwerth, Marie-Therese Dernoscheg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 13, 2021
Adjuvant anti-PD-1 antibody treatment in stage III/IV melanoma: real-world experience and health economic considerationsPeter Koelblinger, Magdalena Hoellwerth, Marie-Therese Dernoscheg, et al.
Pageof 2